why choose us

First received: April 28, 2023

Clinical Trial: REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID

Study Status: Completed

Recruit Status: RECRUITING

Condition: Post-COVID-19 Syndrome

Study Type: INTERVENTIONAL


Official Title: REGAIN: A Randomized, Double Blind, Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in Long COVID

Brief Summary: Following acute COVID-19, some patients develop a group of debilitating symptoms that include fatigue, orthostatic intolerance, difficulty with attention and concentration (often called "brain fog"), myalgias and disrupted sleep.The term Long COVID is used to describe these symptoms after the initial viral infection has passed.These symptoms are the same as those that define myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).A "Proof of Concept" trial showed significant…

Read more